ABSTRACT

Fact Sheet for Healthcare Providers: LumiraDx UK Ltd.; LumiraDx SARS-CoV-2 Antigen (Ag) Test   [open pdf - 142KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Antigen (Ag) Test. The LumiraDx SARS-CoV-2 Ag Test is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider within the first twelve days of the onset of symptoms."

Publisher:
Date:
2020-08-18
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations